Reshaping Retina Treatment with Faricimab, Diplopia in Adults & Neuroprotection for NTG
Date: 11/10/2022 (AEDT)
Venue: The Boathouse - 7 The Blvd, Moonee Ponds , VIC, 3039
Provider: Western Eye Specialists
Contact: Hieu Tran, [E] hieu@westerneyespecialists.com, [P] 9912 2302
Learning Objectives
- Understand the mechanism of action of Faricimab and its potential benefits in the treatment of retinal disease
- Understand the underlying pathophysiology of Sagging Eye Syndrome (SES) & how to diagnose and manage SES both conservatively and surgically, via interactive group discussion of case studies
- Understand why neuroprotection is beneficial in glaucoma patients, the potential role of ginkgo biloba in neuroprotection for NTG & the current available literature around ginkgo biloba and NTG
Max CPD hours awarded: 4
Session Information
| Name |
|---|
| Reshaping Retina Treatment with Faricimab |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.25 |
| Name |
|---|
Diplopia in Adults |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.25 |
| Name |
|---|
Neuroprotection for NGT |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.5 |